Regulation of cytotoxic T lymphocyte responses by dendritic cells: Peaceful coexistence of cross-priming and direct priming?

European Journal of Immunology

Volumn 33, Issue 10, 2003, Pages 2645-2654

  Melief, Cornelis J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cross priming; Cross tolerance; CTL; DC

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN; HLA ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL INTERACTION; CELL MATURATION; CROSS TOLERANCE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DEPLETION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN TRANSPORT; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR CELL; VIRUS INFECTION; ANIMAL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFECTION; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; INFECTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0242366614     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324341     Document Type: Short Survey

References (83)

1. Zinkernagel, R. M., On cross-priming of MHC class I-specific CTL: rule or exception? Eur. J. Immunol. 2002. 32: 2385-2392.
2. Den Haan, J. M. M. and Bevan, M. J., Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. Curr. Opin. Immunol. 2001. 13: 437-441.
3. Ochsenbein, A. F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans, J., Hemmi, S., Hengartner, H. and Zinkernagel, R. M., Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 2001. 411: 1058-1064.
4. Toes, R. E. M., Ossendorp, F., Offringa, R. and Melief, C. J. M., CD4 T cells and their role in antitumor immune responses. J. Exp. Med. 1999. 189: 753-756.
5. Jung, S., Unitmaz, D., Wong, P., Sano, G., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., Pamer, E. G., Littman, D. R. and Lang, R. A., In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T-cells by exogenous cell-associated antigens. Immunity 2002. 17: 211-220.
6. Steinman, R. M. and Nussenzweig, M. C., Avoiding horror autotoxicus. The importance of dendritic cells in peripheral T cell tolerance. Proc. Natl Acad. Sci. USA 2002. 99: 351-358.
7. Shortman, K. and Liu, Y. L., Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002. 2: 151-161.
8. Yewdell, J. W. and Bennink, J. R., Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses, Annu. Rev. Immunol. 1999. 17: 51-88.
9. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. and Amigorena, S., Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002. 20: 621-667.
10. Yewdell, J. W., Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing, Trends Cell Biol. 2001. 11: 294-297.
11. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. and Amigorena, S., Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1999. 1: 362-368.
12. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S. and Bhardwaj, N., Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000. 191: 423-433.
13. Albert, M. L., Kim, J. I. and Birge, R. B., Alpha(v)beta(5) integrin recruits the CrkII-Dock180-Rac1 complex for phagocytosis of apoptotic cells. Nat. Cell Biol. 2000. 2: 899-905.
14. Iyoda, T., Shimoyama, S., Liu, K., Omatsu, Y., Akiyama, Y., Maeda, Y., Takahara, K., Steinman, R. M. and Inaba, K., The CD8(+) dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 2002. 195: 1289-1302.
15. Albert, M. L., Pearce, S. F. A, Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L. and Bhardwaj, N., Immature dendritic cells phagocytose apoptotic cells via alpha(v)beta(5) and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998. 188: 1359-1368.
16. Fonteneau, J. F., Larsson, M. and Bhardwaj, N., Interactions between dead cells and dendritic cells in the induction of antiviral CTL responses. Curr. Opin. Immunol. 2002. 14: 471-477.
17. Liu, K., Iyoda, T., Saternus, M., Kimura, Y., Inaba, K. and Steinman, R. M., Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 2002. 196: 1091-1097.
18. Srivastava, P., Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol, 2002. 2: 185-194.
19. Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C. and Steinman, R. M., Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8(+) T cell tolerance. J. Exp. Med. 2002. 196: 1627-1638.
20. Figdor, C. G., van Kooyk, Y. and Adema, G. J., C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol. 2002. 2: 77-84.
21. Delneste, Y., Magistrelli, G., Gauchat, J.-F., Haeuw, J.-F., Aubry, J.-P., Nakamura, K., Kawakami-Honda, N., Goetsch, L., Sawamura, T., Bonnefoy, J.-Y. and Jeannin, P., Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002. 17: 353-362.
22. Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P. and Amigorena, S., Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 1999. 189: 371-380.
23. Schuurhuis, D. H., Ioan-Facsinay, A., Nagelkerken, B., van Schip, J. J., Sedlik, C., Melief, C. J. M., Verbeek, J. S. and Ossendorp, F., Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8(+) CTL responses in vivo. J. Immunol. 2002. 168: 2240-2246.
24. Kalergis, A. M. and Ravetch, J. V., Inducing tumor immunity through the selective engagement of activating Fc gamma receptors on dendritic cells. J. Exp. Med. 2002. 195: 1653-1659.
25. Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P. and Heath, W. R., Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J. Exp. Med. 1997. 186: 239-245.
26. Kurts, C., Sutherland, R. M., Davey, G., Li, M., Lew, A. M., Blanas, E., Carbone, F. R., Miller, J. F. A. P. and Heath, W. R., CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc. Natl. Acad. Sci. USA 1999. 96: 12703-12707.
27. Spiotto, M. T., Yu, P., Rowley, D. A., Nishimura, M. I., Meredith, S. C., Gajewski, T. F., Fu, Y. X. and Schreiber, H., Increasing tumor antigen expression overcomes "ignorance" to solid tumors via cross-presentation by bone-marrow-derived stromal cells. Immunity 2002. 17: 737-747.
28. Iyoda, T., Shimoyama, S., Liu, K., Omatsu, Y., Akiyama, Y., Maeda, Y., Takahara, K., Steinman, R. M. and Inaba, K., The CD8(+) dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 2002. 195: 1289-1302.
29. Den Haan, J. M. M., Lehar, S. M. and Bevan, M. J., CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 2000. 192: 1685-1695.
30. Belz, G. T., Behrens, G. M. N., Smith, C. M., Miller, J. F. A. P., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R. and Heath, W. R., The CD8 alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 2002. 196: 1099-1104.
31. Heath, W. R. and Carbone, F. R., Cross-presentation, dendritic cells, tolerance and immunity Annu. Rev. Immunol. 2001. 19: 47-64.
32. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C., Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003. 21: 685-711.
33. Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M. and Nussenzweig, M. C., Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001. 194: 769-779.
34. Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C. and Steinman, R. M., Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8(+) T cell tolerance. J. Exp. Med. 2002. 196: 1627-1638.
35. Van Mierlo, G. J. D., den Boer, A. T., Medema, J. P., van der Voort, E. I. H, Fransen, M. F., Offringa, R., Melief, C. J. M. and Toes, R. E. M., CD40 stimulation leads to effective therapy of CD40(-)tumors through induction of strong systemic cytotoxic T lymphocyte immunity. Proc. Natl. Acad. Sci. USA 2002. 99: 5561-5566.
36. Van Stipdonk, M. J., Lemmens, E. E. and Schoenberger, S. P., Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2001. 2: 423-439.
37. Kaech, S. M. and Ahmed, R., Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2001. 2: 415-422.
38. Kaech, S. M., Wherry, E. J. and Ahmed, R., Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2002. 2: 251-262.
39. Melief, C. J. M., Toes, R. E. M., Medema, J. P., van der Burg, S. H., Ossendorp, F. and Offringa, R., Strategies for immunotherapy of cancer. Adv. Immunol. 2000. 75: 235-282.
40. Qin, Z. H., Noffz, G., Mohaupt, M. and Blankenstein, T., Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. J. Immunol. 1997. 159: 770-776.
41. Alexopoulou, L., Holt, A. C., Medzhitov, R. and Flavell, R., Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor 3. Nature 2001. 413: 732-738.
42. Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L. and Schwartz, D. A., TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25: 187-191.
43. Gewirtz, A. T., Navas, T. A., Lyons, S., Godowski, P. J. and Madara, J. L., Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 2001. 167:1882-1885.
44. Hemmi, H., Kaisho, T, Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K. and Akira, S., Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002. 3: 196-200.
45. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K. and Akira, S., A Toll-like receptor recognizes bacterial DNA. Nature 2000. 408: 740-745.
46. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R. and Melief, C. J., T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998. 393: 480-483.
47. Ridge, J. P., Di Rosa, F. and Matzinger, P., A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998. 393: 474-478.
48. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. and Heath, W. R., Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998. 393: 478-480.
49. Lanzavecchia, A. and Sallusto, F., The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 2001. 13: 291-298.
50. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. T., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767-792.
51. Hendriks, J., Gravestein, L. A., Tesselaar, K., van Lier, R. A. W., Schumacher, T. N. M. and Borst, J., CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 2000. 1: 433-440.
52. Chen, A. I., McAdam, A. J., Buhlmann, J. E., Scott, S., Lupher, M. L., Greenfield, E. A., Baum, P. R., Fanslow, W. C., Calderhead, D. M., Freeman, G. J. and Sharpe, A. H., Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity 1999. 11: 689-698.
53. Bansal-Pakala, P., Jember, A. G. H. and Croft, M., Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat. Med. 2001. 7: 907-912.
54. Cooper, D., Bansal-Pakala, P. and Croft, M., 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur. J. Immunol. 2002. 32: 521-529.
55. Diehl, L., van Mierlo, G. J. D., den Boer, A. T., van der Voort, E., Fransen, M., van Bostelen, L., Krimpenfort, P., Melief, C. J. M., Mittler, R., Toes, R. E. M. and Offringa, R., In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway. J. Immunol. 2002. 168: 3755-3762.
56. Hernandez, J., Aung, S., Redmond, W. L. and Sherman, L. A., Phenotypic and functional analysis of CD8+ T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 2001. 194: 707-717.
57. Öhlén, C., Kalos, M., Cheng, L. E., Shur, A. C., Hong, D. J., Carson, B. D., Kokot, N. C. T., Lerner, C. G., Sather, B. D., Huseby, E. S. and Greenberg, P. D., CD8+ T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function. J. Exp. Med. 2002. 195: 1407-1418.
58. Toes, R. E. M., Van der Voort, E. I. H., Schoenberger, S. P., Drijfhout, J. W., Van Bloois, L., Storm, G., Kast, W. M., Offringa, R. and Melief, C. J. M., Enhancement of tumor out-growth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J. Immunol. 1998. 160: 4449-4456.
59. Schuurhuis, D. H., Laban, S., Toes, R. E. M., Ricciardi-Castagnoli, P., Kleijmeer, M. J., Van der Voort, E. I. H., Rea, D., Offringa, R., Geuze, H. J., Melief, C. J. M. and Ossendorp, F., Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J. Exp. Med. 2000. 192: 145-150.
60. Randolph, G. J., Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 2001. 13: 267-274.
61. Geissmann, F., Dieu-Nosjean, M. C., Dezutter, C., Valladeau, J., Kayal, S., Leborgne, M., Brousse, N., Sealand, S. and Davoust, J., Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 2002. 196: 417-430.
62. Randolph, G. J., Is maturation required for Langerhans cell migration? J. Exp. Med. 2002. 196: 413-416.
63. Jolles, S., Christensen, J., Holman, M., Klaus, G. B. and Ager, A., Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin. Clin. Exp. Immunol. 2002. 129: 519-526.
64. Penna, G., Vulcano, M., Sozzani, S. and Adorini, L., Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum. Immunol. 2002. 63: 1164-1171.
65. Shreedhar, V. K., Kelsall, B. L. and Neutra, M. R., Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches. Infect. Immun. 2003. 71: 504-509.
66. Vries, J. M., de Krooshoop, D. J. E. B., Scharenborg, N. M., Lesterhuis, W. J., Diepstra, J. H. S., Muijen, G. N. P., van Strijk, S. P., Ruers, T. J., Boerman, O. C., Oyen, W. J. G., Adema, G. J., Punt, C. J. A. and Figdor, C. G., Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003. 63: 12-17.
67. Jeannin, P., Magistrelli, G. and Herbault, N., Goetsch, L., Godefroy, S., Charbonnier, P., Gonzalez, A., Delneste, Y., Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs. Eur. J. Immunol. 2003, 33: 326-333.
68. Legge, K. L. and Braciale, T. J., Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 2003. 18: 265-277.
69. Zwaveling, S., Ferreira Mota, S. C., Nouta, J., Johnson, M., Lipford, G. P., Offringa, R., Van der Burg, S. H. and Melief, C. J. M., Established human papillomavirus type 16-expressing tumor are effectively eradicated following vaccination with long peptides. J. Immunol. 2002. 169: 350-358.
70. Heckelsmiller, K., Beck, S., Rall, K., Sipos, B., Schlamp, A., Tuma, E., Rothenfusser, S., Endres, S. and Hartmann, G., Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy. Eur. J. Immunol. 2002. 32: 3235-3245.
71. Stanley, M. A., Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin. Exp. Dermatol. 2002. 27: 571-577.
72. Wong, P. and Pamer, E. G., Feedback regulation of pathogen specific T-cell priming. Immunity 2003. 18: 499-511.
73. Albert, M. L., Sauter, B. and Bhardwaj, N., Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTL's. Nature 1998. 392: 86-89.
74. Yrlid, U. and Wick, M. J., Salmonella induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J. Exp. Med. 2000. 4: 613-623.
75. Granucci, F. and Ricciardi-Castagnoli, P., Interactions of bacterial pathogens with dendritic cells during invasion of mucosal surfaces. Curr. Opin. Microbiol. 2003. 6: 72-76.
76. Jeannin, R, Renno, T., Goetsch, L., Miconnet, I., Aubry, J.-P., Delneste, Y., Herbault, N., Baussant, T., Magistrelli, G. and Soulas, C., OmpA targets dendritic cells, induces their maturation and delivers antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Immunol. 2000. 1: 502-509.
77. Sigal, L. J., Crotty, S., Andino, R. and Rock, K. L., Cytotoxic T-cell immunity to virus-infected non-haemopoietic cells requires presentation of exogenous antigen. Nature 1999. 298: 77-80.
78. Sigal, L. J. and Rock, K. L., Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J. Exp. Med. 2000, 192: 1143-1150.
79. Blake, N., Lee, S., Redchenko, I., Thomas, W., Steven, N., Leese, A., Steigerwald-Mullen, P., Kurilla, M. G., Frappier, L. and Rickinson, A., Human CD8+ T-cell responses to EVB EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 1997. 7: 791-802.
80. Blake, N., Haigh, T., Schaka'a, G., Croom-Carter, D. and Rickinson, A., The importance of exogenous antigen in priming the human CD8+ T-cell response: lessons from the EVB nuclear antigen EBNA1. J. Immunol. 2000. 165: 7078-7087.
81. Ossendorp, F., Mengedé, E., Camps, M., Filius, R. and Melief, C. J. M., Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J. Exp. Med. 1998. 187: 693-702.
82. Janssen, E. M., Lemmers, E. E., Wolfe, T., Christen, U., von Herrath, M. G. and Schoenberger, S. P., CD4+ T-cells are required for secondary expansion and memory in CD8+ T-cells. Nature 2003. 421: 852-856.
83. Bourgeois, C., B. Rocka, B. and Tauchot, C., A role for CD40 expression on CD8+ T-cells in the generation of CD8+ T-cell memory. Science 2002. 297: 2060-2063.